[go: up one dir, main page]

BR9608730A - Use of benzimidazoles for the production of a medicine for the treatment of leukemia - Google Patents

Use of benzimidazoles for the production of a medicine for the treatment of leukemia

Info

Publication number
BR9608730A
BR9608730A BR9608730A BR9608730A BR9608730A BR 9608730 A BR9608730 A BR 9608730A BR 9608730 A BR9608730 A BR 9608730A BR 9608730 A BR9608730 A BR 9608730A BR 9608730 A BR9608730 A BR 9608730A
Authority
BR
Brazil
Prior art keywords
benzimidazoles
leukemia
medicine
treatment
production
Prior art date
Application number
BR9608730A
Other languages
Portuguese (pt)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9608730A publication Critical patent/BR9608730A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9608730A 1995-06-07 1996-05-22 Use of benzimidazoles for the production of a medicine for the treatment of leukemia BR9608730A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47381795A 1995-06-07 1995-06-07
PCT/US1996/007445 WO1996040122A1 (en) 1995-06-07 1996-05-22 Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia

Publications (1)

Publication Number Publication Date
BR9608730A true BR9608730A (en) 1999-06-29

Family

ID=23881113

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608730A BR9608730A (en) 1995-06-07 1996-05-22 Use of benzimidazoles for the production of a medicine for the treatment of leukemia

Country Status (17)

Country Link
EP (1) EP0831816A1 (en)
JP (1) JPH11506732A (en)
KR (1) KR19990022617A (en)
CN (1) CN1186433A (en)
AR (1) AR003137A1 (en)
AU (1) AU717382B2 (en)
BR (1) BR9608730A (en)
CA (1) CA2223435A1 (en)
CZ (1) CZ391197A3 (en)
HU (1) HUP9802634A3 (en)
IL (1) IL118424A0 (en)
NO (1) NO975660L (en)
PL (1) PL324026A1 (en)
SK (1) SK168697A3 (en)
TR (1) TR199701536T1 (en)
WO (1) WO1996040122A1 (en)
ZA (1) ZA964373B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) * 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL134354C (en) * 1963-05-23
FR2155888A1 (en) * 1971-10-13 1973-05-25 Agot Aime Solid anthelmintic composn - for more economical treatment of ruminants
NZ305784A (en) * 1995-04-12 2001-03-30 Procter & Gamble Benzimidazole containing medicaments for treating cancers, tumors and viral infections

Also Published As

Publication number Publication date
HUP9802634A2 (en) 1999-03-29
HUP9802634A3 (en) 1999-05-28
IL118424A0 (en) 1996-09-12
CN1186433A (en) 1998-07-01
AU717382B2 (en) 2000-03-23
ZA964373B (en) 1996-09-02
TR199701536T1 (en) 1998-02-21
CZ391197A3 (en) 1998-05-13
NO975660L (en) 1998-02-09
AU5802096A (en) 1996-12-30
CA2223435A1 (en) 1996-12-19
KR19990022617A (en) 1999-03-25
PL324026A1 (en) 1998-05-11
NO975660D0 (en) 1997-12-05
EP0831816A1 (en) 1998-04-01
AR003137A1 (en) 1998-07-08
WO1996040122A1 (en) 1996-12-19
JPH11506732A (en) 1999-06-15
SK168697A3 (en) 1998-12-02

Similar Documents

Publication Publication Date Title
BR9609093A (en) Use of bis-1,2,4-triazoles for the production of a cancer treatment drug
CY2013020I1 (en) THE USE OF AN INGENANE COMPOUND FOR THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF CANCER
DE69839241D1 (en) Holding device for the production of precision parts
NO905431L (en) PRESSURE APPLICANT FOR MEDICINE.
AR002651A1 (en) Integrated procedure for the production of 1-butene
FI973281L (en) Process for the preparation of certain azacyclohexapeptides
BR9608730A (en) Use of benzimidazoles for the production of a medicine for the treatment of leukemia
KR900011474A (en) Treatment for thrombocytopenia
NO901486L (en) PHOTOPOLYMERIZABLE COATING MATERIAL.
ITGE930053A1 (en) DEVICE FOR THE MANUFACTURE OF WADDING.
NO921040L (en) STIMULATING FACTOR FOR THE NEW RECEPTOR
KR920700625A (en) Kidney-selective prodrug for the treatment of hypertension
PT1083934E (en) EGR-1 FOR THE PRODUCTION OF A WOUND TREATMENT MEDICINE
NO903371D0 (en) COATING COMPOUNDS.
FI935065A0 (en) Pharmaceutical production
EE03384B1 (en) Use of melatonin for the manufacture of a medicament
FI933755A7 (en) Process for the preparation of trans-piperidine-2,5-dicarboxylates
FI943759A0 (en) For the purposes of organic production
FI973644A0 (en) A new process for the preparation of 2,3-dihydrobenzofuranol derivatives
DK101197A (en) Drug for the treatment of thrombocytopenia
PT866699E (en) USE OF COLINESTERASE INHIBITORS FOR THE MANUFACTURE OF A MEDICATION FOR THE TREATMENT OF XEROSTOMY
FI964410A7 (en) Process for the preparation of 4-amino-delta4-3-ketosteroids via 4-nitro-delta4-3-ketosteroids
DE59406095D1 (en) Device for the continuous production of multilayer, flat materials
LV11966A (en) Anti-inflammatory medication for use
FI972694A0 (en) A new process for the preparation of sameridine

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal